According to research by The Insight Partners, the global Skin Care Devices Market accounted for $10,898.26 million in 2021 and is projected to reach $23,378.96 million by 2028, growing at a stellar CAGR of 11.5% from 2021-2028. Strategic cooperations are the key parameters for market expansion.

The rising cases of skin diseases like dermatitis, acne, psoriasis, warts, birthmarks and lesions are creating the demand for skin care products and devices. According to the American Academy of Dermatology Association, acne is the most common skin condition in the United States, affecting over 50 million people annually. In addition, the changing ideals of beauty and the cosmetics industry are attracting customers to their skin care products. The growing geriatric population, prone to wrinkles and aging, demands anti-aging, firming and skin rejuvenation treatments. According to the Aesthetic Society, 41,301 skin rejuvenation procedures were performed in the United States, generating $31,567,167 in revenue in 2020.

Download an exclusive sample PDF copy of the market study @ https://www.theinsightpartners.com/sample/TIPMD00002253/

Major players dominating the global Skin Care Devices Market are Allergan Plc; Cutera, Inc.; Merz Pharma; Hologic, Inc.; Candela Medical; Panasonic Corporation; Michelson Diagnostics Ltd.; Bausch Health Companies Inc.; Lumenis Be Ltd; and PhotoMedex among others.

• In March 2019, Allergan Plc acquired Envy Medical Inc, a private medical aesthetics company.
• In September 2019, Cutera Inc received approval from Health Canada for its truSculp iD, a body contouring platform.
• In November 2019, Merz Pharma launched the Ultratherapy skin tightening treatment in India.
• In January 2020, Candela Medical entered into an exclusive agreement with MT.DERM GmbH for the commercialization of their medical micro-needling products.

skin diseases…